AC
STJ

Alexandria Capital’s St Jude Medical STJ Stock Holding History

Alexandria Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-65
Closed -$5K – 677
2016
Q4 		$5K Hold
65
– – ﹤0.01% 490
2016
Q3 		$5K Hold
65
– – ﹤0.01% 502
2016
Q2 		$5K Hold
65
– – ﹤0.01% 492
2016
Q1 		$4K Hold
65
– – ﹤0.01% 526
2015
Q4 		$4K Hold
65
– – ﹤0.01% 570
2015
Q3 		$4K Hold
65
– – ﹤0.01% 511
2015
Q2 		$5K Hold
65
– – ﹤0.01% 504
2015
Q1 		$4K Hold
65
– – ﹤0.01% 527
2014
Q4 		$4K Hold
65
– – ﹤0.01% 494
2014
Q3 		$4K Hold
65
– – ﹤0.01% 481
2014
Q2 		$5K Hold
65
– – ﹤0.01% 456
2014
Q1 		$4K Hold
65
– – ﹤0.01% 498
2013
Q4 		$4K Hold
65
– – ﹤0.01% 509
2013
Q3 		$3K Hold
65
– – ﹤0.01% 551
2013
Q2 		$3K Buy
+65
New +$2.82K ﹤0.01% 603

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alexandria Capital's STJ Position: Q1 2017 in Review

Alexandria Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 65 shares — an estimated $5K sold.

Alexandria Capital first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $5K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Alexandria Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Alexandria Capital sold 65 St Jude Medical shares in Q1 2017, an estimated $5K.
  • Alexandria Capital first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Alexandria Capital's St Jude Medical position peaked at $5K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Alexandria Capital's 13F filing for Q1 2017, filed 25 Apr 2017.